MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond

Related Experiment Video

Updated: Mar 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.1K

Jean-Christophe Marine1, Aart G Jochemsen2

  • 1Laboratory for Molecular Cancer Biology, Center for the Biology of Disease, VIB, 3000 Leuven, Belgium Laboratory for Molecular Cancer Biology, Center of Human Genetics, KULeuven, 3000 Leuven, Belgium.

Cold Spring Harbor Perspectives in Medicine
|July 3, 2016
PubMed

Insights

Cancer cells up-regulate MDMX protein to suppress the tumor suppressor p53. Targeting MDMX, particularly using antisense oligonucleotides (ASOs) to modulate MDMX mRNA splicing, presents a promising cancer therapy strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • MDMX is a protein that interacts with p53, similar to MDM2.
  • MDMX and MDM2 have essential, nonredundant roles in regulating p53 activity during embryonic development.
  • Cancer cells often increase MDMX expression to inhibit the tumor-suppressive function of p53.

Purpose of the Study:

  • To summarize how cancer cells enhance MDMX expression.
  • To review potential therapeutic strategies targeting MDMX in cancer treatment.
  • To highlight the use of antisense oligonucleotides (ASOs) for modulating MDMX mRNA splicing.

Main Methods:

  • Review of existing scientific literature on MDMX function and regulation in cancer.
  • Analysis of mechanisms driving increased MDMX expression in cancerous cells.
  • Evaluation of pharmacological approaches targeting MDMX, including ASO-based strategies.

Main Results:

  • MDMX plays a critical role in oncogenesis, partly through its interaction with p53.
  • MDMX exhibits p53-independent functions that contribute to cancer development.
  • Increased MDMX expression is a common mechanism employed by tumors to evade p53-mediated tumor suppression.
  • Antisense oligonucleotides (ASOs) demonstrate potential for effectively targeting MDMX mRNA splicing.

Conclusions:

  • MDMX is a significant therapeutic target for various cancers.
  • Understanding the mechanisms of MDMX overexpression is key to developing effective cancer therapies.
  • ASO-mediated modulation of MDMX mRNA splicing offers a novel and promising strategy for cancer treatment.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

2.1K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K